Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ebert

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
JAMA Network Open|November 14, 2019
Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During SpaceflightKarina Marshall-Goebel, Steven S Laurie, Irina V Alferova, et al.
Molecular Neurodegeneration|December 19, 2018
Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal modelHong Wang, Yupeng Li, John W Ryder, et al.
Oncotarget|February 21, 2020
A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertibWayne D Blosser, Jack A Dempsey, Ann M McNulty, et al.
Scientific Data|October 13, 2020
Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regionsSolveig K Sieberts, Thanneer M Perumal, Minerva M Carrasquillo, et al.
Oncotarget|March 24, 2018
Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumorsBruce W Konicek, Andrew R Capen, Kelly M Credille, et al.
Scientific Reports|October 27, 2019
Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patientsSteven M Bray, Jeeyun Lee, Seung Tae Kim, et al.
JAMA|January 21, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialRobert L Gottlieb, Ajay Nirula, Peter Chen, et al.
The Lancet. Oncology|September 30, 2021
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 studyJuan W Valle, Arndt Vogel, Crystal S Denlinger, et al.
Cancer Research|September 6, 2014
Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokersVidhya G Krishnan, Philip J Ebert, Jason C Ting, et al.
The New England Journal of Medicine|July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
JAMA Network Open|November 14, 2019
Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During SpaceflightKarina Marshall-Goebel, Steven S Laurie, Irina V Alferova, et al.
Molecular Neurodegeneration|December 19, 2018
Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal modelHong Wang, Yupeng Li, John W Ryder, et al.
Oncotarget|February 21, 2020
A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertibWayne D Blosser, Jack A Dempsey, Ann M McNulty, et al.
Scientific Data|October 13, 2020
Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regionsSolveig K Sieberts, Thanneer M Perumal, Minerva M Carrasquillo, et al.
Oncotarget|March 24, 2018
Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumorsBruce W Konicek, Andrew R Capen, Kelly M Credille, et al.
Scientific Reports|October 27, 2019
Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patientsSteven M Bray, Jeeyun Lee, Seung Tae Kim, et al.
JAMA|January 21, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialRobert L Gottlieb, Ajay Nirula, Peter Chen, et al.
The Lancet. Oncology|September 30, 2021
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 studyJuan W Valle, Arndt Vogel, Crystal S Denlinger, et al.
Cancer Research|September 6, 2014
Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokersVidhya G Krishnan, Philip J Ebert, Jason C Ting, et al.
The New England Journal of Medicine|July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Pageof 26